If you’ve worked in drug development, whether it be at a biotech or pharma company, you know just how critical Good Laboratory Practice (GLP) toxicology studies are in the preclinical process. These studies help evaluate the safety and potential risks associated with...
Preclinical studies are essential for advancing oncology drug development programs. They provide valuable insights into a drug candidate's safety and efficacy before it moves into clinical trials. A well-designed preclinical study can increase the likelihood of...
Safety pharmacology and toxicology studies are performed to understand the onset, degree of severity, and time length up to which a particular dose of a new drug demonstrates any toxic effects. The dosing regimens for such studies usually range from acute studies...
- Preclinical toxicology is a critical component of the drug development process. The goal of toxicology testing is to support the transition of a new drug candidate to patients in Phase I clinical studies through an investigational new drug (IND) filing. The IND...
Noble Life Sciences now offers Digital PCR services and expands Molecular Biology Facility’s capability for cell and gene therapy applications. Our digital PCR services utilizes the Qiagen QIAcuity four-plate digital PCR (dPCR) instrument that detects up to 5...
Cell and gene therapies have the potential to change the way rare diseases are treated, offering novel and more effective treatments for patients with limited options. This article explores the various options available from the government to help rare disease drug...
Small businesses in the United States are afforded the opportunity to develop technological or scientific innovations through grant programs such as the SBIR, STTR, DOD, and NSF. These highly competitive programs are one of the largest sources of capital for funding...
The Cancer Genome Atlas (TCGA)—a comprehensive and coordinated effort to accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies, supported by the National Cancer Institute and National Human Genome Research...
Sepsis is one of the 10 leading causes of death worldwide. According to the Centers for Disease Control, more than 1.5 million people in the United States contract sepsis yearly, and around 250,000 of these people die from its associated complications. In 2015, sepsis...
The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison of the United States and Tasuku Honjo of Japan for their work on unleashing the body’s immune system to attack cancer, a breakthrough that has herald in an entirely new class of treatment...